Skip to main content

Year: 2023

Three Sixty Solar 2023 Drives Momentum into New Year

VANCOUVER, British Columbia, Dec. 29, 2023 (GLOBE NEWSWIRE) — Three Sixty Solar Ltd. (NEO: VSOL) (OTC: VSOLF) (“Three Sixty,” “Three Sixty Solar,” or the “Company”), an innovative alternative energy design, manufacture, and sales organization focused on solar equipment supply to the global marketplace, is pleased with the important progress achieved in 2023 and looks forward to an exciting year ahead. Key Points:2023 saw Three Sixty’s sales process deliver its first solar tower purchase order in November. All sales orders to-date have commenced with the issuance of a letter of intent (LOI), with two additional LOI commitments outstanding. Positive initial reviews have been received regarding the Company’s vertical solar tower technology patents encompassing the United States, Canada, Europe, and Africa. Extensive research has...

Continue reading

LNG Energy Group Announces Additional Shareholder Alignment Initiatives

TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) — LNG Energy Group Corp. (TSXV: LNGE) (TSXV: LNGE.WT) (OTCQB: LNGNF) (FRA: 6MH) (the “Company” or “LNG Energy Group”) announced today additional shareholder alignment initiatives. These measures are meant to further align the directors, officers and employees of the Company with its shareholders. Shareholder Alignment Initiatives As previously announced on September 28, 2023, the Chief Financial Officer, Angel Roa, and its Chief Operating Officer, Nicolas Ziperovich, agreed to settle certain management and consulting fees owed to them, respectively, (collectively, the “Debt”), in common shares in the capital of the Company (“Common Shares”). Mr. Roa has agreed to receive 269,280 Common Shares at a deemed price of $0.50 per share and Mr. Ziperovich has agreed to receive 157,080 Common Shares...

Continue reading

Neutra Reflects on 2023 and Looks Forward to 2024

HOUSTON, TX, Dec. 29, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — Neutra Corporation (OTC PINK:NTRR), an emerging health and wellness research and development company, reflects on the 2023 year and plans for moving forward in 2024. In the previous press release, Neutra announced a medium-term management plan to meet the rapidly increasing demand for the company’s modern approach to specialty health and wellness solutions. Currently, the acquisition has been put on hold due to some internal housekeeping that Neutra must resolve before moving forward. After the internal issues have been resolved, Neutra and Mercury plan to reopen the acquisition through a renewed Letter of Intent. In the interim, Mercury has contracted Neutra’s services via the “Clinical Foundations” service model. “We understand that this postpones the...

Continue reading

Azincourt Energy Corp. Closes Second Tranche of Private Placement

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 29, 2023 (GLOBE NEWSWIRE) — AZINCOURT ENERGY CORP. (“Azincourt” or the “Company”) (TSX.V: AAZ), is pleased to announce it has closed a second tranche of its non-brokered private placement. In connection with closing of the second tranche, the Company has issued 500,000 non-flow-through units (each, an “NFT Unit”) and 5,714,286 flow-through units (each, an “FT Unit”). Each NFT Unit was offered at a price of $0.03 and each FT Unit was offered at a price of $0.035. Each NFT Unit and FT Unit consists of one common share and one share purchase warrant entitling the holder to acquire an additional common share of the Company at a price of $0.05 until December 29, 2026. When combined with the earlier...

Continue reading

BlueRush Inc. Releases Fiscal Q1 2024 Results

TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) — BlueRush Inc. (“BlueRush” or the “Company“) ‎‎‎(TSXV:BTV; OTCQB:BTVRF), ‎a pioneering personalized video Software as a Service (“SaaS“) company, in its recent financial quarter ending October 31, 2023, reported a challenging quarter compared to the same period in the previous year. This press release provides an overview of the Company’s performance, underlying factors, strategic responses, and outlook for the future. Financial HighlightsSaaS Revenues (defined below): Decreased by 15% to $644,914 in Q1 2024, compared to $756,024 in Q1 2023. Gross Profit: Witnessed a 40% decrease, amounting to $482,682 in Q1 2024 versus $844,587 in Q1 2023. Total Operating Expenses: Decreased by 20% or $284,446, totaling $1,169,983 in Q1 2024 compared to $1,454,384 in...

Continue reading

Hampton Financial Corporation Announces 4th Quarter and Full Year Results for 2023

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) — Hampton Financial Corporation (“Hampton” or the “Company”, TSXV:HFC) today announced its financial results for the 4th Quarter and full year ended August 31, 2023. “The fourth quarter and full year results reflect continued pressures on Revenues and Earnings across our industry that began in the fall of 2022 and continued well into calendar 2023. Capital Markets activity continued to be weak into the fourth quarter, but we are seeing signs of an initial recovery that should be reflected in Q2 of fiscal 2024,” said Hampton Executive Chairman & CEO Peter Deeb. Fourth Quarter fiscal highlights: Fourth Quarter ended August 31st, 2023;Q4 Revenues of $1,360,000; a decrease of 42.9% year-over-year Q4...

Continue reading

Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic

SOUTH SAN FRANCISCO, Calif., Dec. 29, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that a second leading independent proxy advisory firm, Glass, Lewis & Co. (“Glass Lewis”), has recommended that all Standard BioTools stockholders vote “FOR” all proposals relating to the pending merger with SomaLogic at the Company’s upcoming Special Meeting of Stockholders to be held on January 4, 2024. The Company issued the following statement: The recommendations from both leading proxy advisory firms – Glass Lewis and ISS – to support the proposed merger with SomaLogic reaffirms our belief in the strength of the combined company and the significant growth potential ahead. We urge all stockholders to follow these recommendations...

Continue reading

Parks! America Responds to the Purported Notice of Shareholder Demand for Special Meeting

PINE MOUNTAIN, Georgia, Dec. 29, 2023 (GLOBE NEWSWIRE) — Parks! America, Inc. (OTCPink: PRKA) (the “Company”) received on December 22, 2023, a purported notice (the “Purported Notice”) from Focused Compounding Fund, LP (“Focused Compounding”) as to the demand that the Company hold a special meeting of shareholders of the Company (if held, the “Special Meeting”). Pursuant to the Purported Notice, the Special Meeting would be held for shareholders to vote on a number of proposals, including a proposal for the removal of all directors currently serving on the Company’s Board of Directors and a proposal for the election of an entirely new Board of Directors consisting of only three directors. If the proposals were approved, the Board would decrease from seven directors to three directors – with two of the three new directors being...

Continue reading

PharmAla Files Audited Financials for Year Ending August 31, 2023

Highlights include Revenue Growth, Expansion of IP Licensing, and formation of Cortexa Joint Venture VANCOUVER, British Columbia, Dec. 29, 2023 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is pleased to file its audited financial statements for the year ended on August 31, 2023. Following is a short list of the company’s achievements in the relevant period: – PharmAla became the first publicly traded company to produce GMP MDMA, and the first company to release its LaNeo™ GMP MDMA Drug Product– PharmAla became the first company to treat patients for PTSD with MDMA in Canada through the Special Access Program– PharmAla...

Continue reading

AI Transportation Acquisition Corp Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 2, 2024

New York, NY, Dec. 29, 2023 (GLOBE NEWSWIRE) — AI Transportation Acquisition Corp (the “Company”), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced that holders of the Company’s units may elect to separately trade the underlying ordinary shares and rights included in its units commencing on or about January 2, 2024. The ordinary shares and rights will trade on The Nasdaq Capital Market (“NASDAQ”) under the symbols AITR and AITRR, respectively. Any Units not separated will continue to trade on NASDAQ under the symbol AITRU. About AI Transportation Acquisition Corp. AI Transportation Acquisition Corp. The Company is a blank check company formed for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.